A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The transforming genes of oncogenic retroviruses are homologous to a group of evolutionary conserved cellular onc genes. The human cellular homologue (c-abl) of the transforming sequence of Abelson murine leukaemia virus (A-MuL V) was recently shown to be located on chromosome 9. The long arm of this chromosome is involved in a specific translocation with chromosome 22, the Philadelphia translocation (Ph1), t(9; 22) (q34, q11), which occurs in patients with chronic myelocytic leukaemia (CML)3-5. Here we investigate whether the c-abl gene is included in this translocation. Using c-abl and v-abl hybridization probes on blots of somatic cell hybrids, positive hybridization is found when the 22q- (the Philadelphia chromosome), and not the 9q+ derivative of the translocation, is present in the cell hybrids. From this we conclude that in CML, c-abl sequences are translocated from chromosome 9 to chromosome 22q-. This finding is a direct demonstration of a reciprocal exchange between the two chromosomes and suggests a role for the c-abl gene in the generation of CML.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The importance of proto-oncogenes was further highlighted by discoveries that nonviral cancers frequently have genetic alterations in proto-oncogenes that activate them and drive oncogenesis—for example, mutations in H-ras or K-ras (76), gene amplification of c-myc (77), and chromosomal translocation/activation involving c-abl (78).”
From The Discovery of Reverse Transcriptase (2016) · cites this paper as [78]
Citations
Cites
ROWLEY, J. D. (1973) · Nature · doi:10.1038/243290a0 · Cited by 4,291
Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene
Parada, L. F., Tabin, C. J., Shih, C., & Weinberg, R. A. (1982) · Nature · doi:10.1038/297474a0 · Cited by 944
Der, C. J., Krontiris, T. G., & Cooper, G. M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.11.3637 · Cited by 800
A physical map of the DNA regions flanking the rabbit β-globin gene
Jeffreys, A. (1977) · Cell · doi:10.1016/0092-8674(77)90119-2 · Cited by 644
Santos, E., Tronick, S. R., Aaronson, S. A., Pulciani, S., & Barbacid, M. (1982) · Nature · doi:10.1038/298343a0 · Cited by 623
Chang, E. H., Furth, M. E., Scolnick, E. M., & Lowy, D. R. (1982) · Nature · doi:10.1038/297479a0 · Cited by 587
Abelson murine leukaemia virus protein is phosphorylated in vitro to form phosphotyrosine
Witte, O. N., Dasgupta, A., & Baltimore, D. (1980) · Nature · doi:10.1038/283826a0 · Cited by 530
Goff, S. P., Gilboa, E., Witte, O. N., & Baltimore, D. (1980) · Cell · doi:10.1016/0092-8674(80)90554-1 · Cited by 470
Khan, P. M. (1971) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(71)80007-3 · Cited by 344
Chromosomal localization of human cellular homologues of two viral oncogenes
Heisterkamp, N., Groffen, J., Stephenson, J. R., Spurr, N. K., Goodfellow, P. N., Solomon, E., Carritt, B., & Bodmer, W. F. (1982) · Nature · doi:10.1038/299747a0 · Cited by 303
Self-citation
Research works printed but not linked: 2
- Heisterkamp, N., Groffen, J. & Stephenson, J. R. J. molec. appl. Genet. (in the press).
- Ferguson-Smith, M. A. & Aitken, D. A. Cytogenet. Cell Genet. 22, 49–451 (1978).
Cited by
Items 201–300 of 1,000
STI-571: an anticancer protein-tyrosine kinase inhibitor
Roskoski, R. J. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.08.055 · Cited by 127
Myc/Ig juxtaposition by chromosomal translocations: some new insights, puzzles and paradoxes
Klein, G., & Klein, E. (1985) · Immunology Today · doi:10.1016/0167-5699(85)90036-2 · Cited by 112
Metabolism considerations for kinase inhibitors in cancer treatment
Duckett, D. R., & Cameron, M. D. (2010) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2010.506873 · Cited by 113
“CML is the result of the genetic translocation of the c-abl oncogene from chromosome 9 to the breakpoint cluster region (bcr) on chromosome 22 [1,2], yielding a bcr-abl fusion with constitutive ABL kinase activity referred to as BCR-ABL.”
Consistent involvement of the bcr gene by 9;22 breakpoints in pediatric acute leukemias
Suryanarayan, K., Hunger, S. P., Köhler, S., Carroll, A. J., Crist, W., Link, M., & Cleary, M. L. (1991) · Blood · doi:10.1182/blood.v77.2.324.324 · Cited by 111
“cytogenetic features such as t(4;ll) (q21;q23) or t(8;14) (q24;q32) that would explain their early treatment failure (data not shown).”
Thiele, C. J., McKeon, C., Triche, T. J., Ross, R. A., Reynolds, C. P., & Israel, M. A. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113137 · Cited by 109
Side-effects profile and outcomes of ponatinib in the treatment of chronic myeloid leukemia
Chan, O., Talati, C., Isenalumhe, L. L., Shams, S. R., Nodzon, L., Fradley, M. G., Sweet, K. L., & Pinilla-Ibarz, J. A. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019000268 · Cited by 114
Preferential induction of RET/PTC1 rearrangement by X-ray irradiation
Mizuno, T., Iwamoto, K. S., Kyoizumi, S., Nagamura, H., Shinohara, T., Koyama, K., Seyama, T., & Hamatani, K. (2000) · Oncogene · doi:10.1038/sj.onc.1203343 · Cited by 108
“Therefore, the BCR±ABL fusion gene was also observed in addition to RET/PTC. BCR±ABL is the well-known product of a reciprocal translocation between chromosome 9 and 22 associated with chronic myelogenous leukemia (CML) (Chan et al., 1987; de Klein et al., 1982).”
BackgroundCristofano, A. D., Niki, M., Zhao, M., Karnell, F. G., Clarkson, B. D., Pear, W. S., Aelst, L. V., & Pandolfi, P. P. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.3.275 · Cited by 108
“Chronic myelogenous leukemia (CML) * is a clonal disorder of the hematopoietic cells characterized by the presence of the Philadelphia chromosome (Ph ), which is the result of a chromosomal translocation between the BCR gene on chromosome 22 and the ABL gene on chromosome 9 (1).”
BackgroundMyxoid chondrosarcoma with a translocation involving chromosomes 9 and 22
Hinrichs, S. H., Jaramillo, M. A., Gumerlock, P. H., Gardner, M. B., Lewis, J. P., & Freeman, A. E. (1985) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(85)90187-6 · Cited by 107
Role of bone marrow matrix in normal and abnormal hematopoiesis
Verfaillie, C. M., Hurley, R., Bhatia, R., & McCarthy, J. B. (1994) · Critical Reviews in Oncology/Hematology · doi:10.1016/1040-8428(94)90071-x · Cited by 107
Rowley, J. D. (1990) · PubMed · Cited by 107
Philadelphia chromosome‐negative chronic myelogenous leukaemia: a morphological reassessment
Pugh, W. C., Pearson, M., Vardiman, J. W., & Rowley, J. D. (1985) · British Journal of Haematology · doi:10.1111/j.1365-2141.1985.tb07443.x · Cited by 107
Our changing view of the genomic landscape of cancer
Bell, D. W. (2009) · The Journal of Pathology · doi:10.1002/path.2645 · Cited by 126
Localization of c-ras oncogene family on human germ-line chromosomes.
Jhanwar, S. C., Neel, B. G., Hayward, W. S., & Chaganti, R. S. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.15.4794 · Cited by 106
ABL1 fusion genes in hematological malignancies: a review
Braekeleer, E. D., Douet‐Guilbert, N., Rowe, D. W., Bown, N. P., Morel, F., Berthou, C., Férec, C., & Braekeleer, M. D. (2011) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2011.01586.x · Cited by 119
“t(9;22)(q34;q11)(1) BCR-ABL1 Ph-positive CML 100% (6, 24, 51) t(9;22)(q34;q11)(1) BCR-ABL1 Pediatric B-cell ALL 3–5% (19) t(9;22)(q34;q11)(1) BCR-ABL1 Adult B-cell ALL 25–30% (19) t(9;22)(q34;q11)(1) BCR-ABL1 AML Rare (4, 39, 40) t(9;22)(q34;q11)(1) BCR-ABL1 T-cell ALL Rare (21–23) t(9;12)(q34;p13)(2) ETV6-ABL1 AML Th…”
BackgroundLukášová, E., Kozubek, S., Kozubek, M., Kjeronská, J., Rýznar, L., Horáková, J., Krahulcová, E., & Horneck, G. (1997) · Human Genetics · doi:10.1007/s004390050547 · Cited by 105
Naumann, S., Reutzel, D., Speicher, M. R., & Decker, H.-J. (2001) · Leukemia Research · doi:10.1016/s0145-2126(00)00125-9 · Cited by 104
Increased numbers of marrow basophils may be associated with a t(6;9) in ANLL
Pearson, M., Vardiman, J. W., Beau, M. M. L., Rowley, J. D., Schwartz, S., Kerman, S. L., Cohen, M. M., Fleischman, E. W., & Prigogina, E. L. (1985) · American Journal of Hematology · doi:10.1002/ajh.2830180409 · Cited by 104
Treatment for chronic myelogenous leukemia: the long road to imatinib
Hunter, T. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31691 · Cited by 103
Clemons, N. J., McColl, K. E. L., & Fitzgerald, R. C. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.06.061 · Cited by 113
Isolation and sequence analysis of a novel human tyrosine kinase gene.
Hao, Q. L., Heisterkamp, N., & Groffen, J. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.4.1587 · Cited by 103
Self-citationBcr-Abl inhibition as a modality of CML therapeutics
Buchdunger, E., Matter, A., & Druker, B. J. (2001) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(01)00022-1 · Cited by 102
c-sis is translocated from chromosome 22 to chromosome 9 in chronic myelocytic leukemia.
Groffen, J., Heisterkamp, N., Stephenson, J. R., van Kessel, A. G., de Klein, A., Grosveld, G. C., & Bootsma, D. (1983) · The Journal of Experimental Medicine · doi:10.1084/jem.158.1.9 · Cited by 101
Self-citationCML patients in blast crisis have breakpoints localized to a specific region of the BCR
Schaefer-Rego, K. E., Dudek, H., Popenoe, D., Arlin, Z. A., Mears, J., Bank, A., & Leibowitz, D. S. (1987) · Blood · doi:10.1182/blood.v70.2.448.448 · Cited by 101
Bartram, C., de Klein, A., Hagemeijer, A., Grosveld, G. C., Heisterkamp, N., & Groffen, J. (1984) · Blood · doi:10.1182/blood.v63.1.223.223 · Cited by 101
Self-citationKarnieli, E., Werner, H., Rauscher, F. J., Benjamin, L. E., & LeRoith, D. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19304 · Cited by 101
Cytogenetic studies in primary gastric cancer
Ochi, H., Douglass, H. O., & Sandberg, A. A. (1986) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(86)90022-1 · Cited by 99
Rearrangement of the bcr Gene in Philadelphia-Chromosome-Negative Chronic Myeloid Leukemia
Ganesan, T., Rassool, F. V., Guo, A., Young, B. D., Galton, D. A. G., & Goldman, J. M. (1987) · Hämatologie und Bluttransfusion · doi:10.1007/978-3-642-72624-8_33 · Cited by 99
Shtalrid, M., Talpaz, M., Kurzrock, R., Kantarjian, H., Trujillo, J. M., Gutterman, J. U., Yoffe, G., & Blick, M. B. (1988) · Blood · doi:10.1182/blood.v72.2.485.485 · Cited by 98
Activity of tyrosine kinase inhibitors against human NUP214-ABL1-positive T cell malignancies
Quintás‐Cardama, A., Tong, W.-G., Manshouri, T., Vega, F., Lennon, P. A., Cools, J., Gilliland, D. G., Lee, F. Y., Cortes, J. E., Kantarjian, H. M., et al. (2008) · Leukemia · doi:10.1038/leu.2008.80 · Cited by 97
The history of myeloproliferative disorders: before and after Dameshek
Tefferi, A. (2007) · Leukemia · doi:10.1038/sj.leu.2404946 · Cited by 127
Eibl, B., Ebner, S., Duba, C., Böck, G., Romani, N., Erdel, M., Gächter, A., Niederwieser, D. W., & Schuler, G. (1997) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199711)20:3<215::aid-gcc1>3.0.co;2-5 · Cited by 97
Bartholomeusz, G. A., Talpaz, M., Kapuria, V., Kong, L. Y., Wang, S., Estrov, Z. E., Priebe, W., Wu, J. Y., & Donato, N. J. (2007) · Blood · doi:10.1182/blood-2006-02-005579 · Cited by 97
The karyotype of blastic crisis
Alimena, G., Cuia, M. R. D., Diverio, D., Gastaldi, R., & Nanni, M. (1987) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(87)90131-2 · Cited by 93
Shifting paradigms: the seeds of oncogene addiction
Sawyers, C. L. (2009) · Nature Medicine · doi:10.1038/nm1009-1158 · Cited by 93
Mayerhofer, M., Gleixner, K. V., Mayerhofer, J., Hoermann, G., Jaeger, E., Aichberger, K. J., Ott, R. G., Greish, K. F., Nakamura, H., Derdak, S. V., et al. (2007) · Blood · doi:10.1182/blood-2006-11-055723 · Cited by 96
Clinical Targeting of Mutated and Wild-Type Protein Tyrosine Kinases in Cancer
Drake, J. M., Lee, J. K., & Witte, O. N. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01592-13 · Cited by 103
“This chromosomal abnormality mapped the cellular oncogene c-ABL from chromosome 9 to the breakpoint cluster region (BCR) of chromosome 22, creating the BCR-ABL fusion gene (68, 69).”
BackgroundAnafi, M., Gazit, A., Gilon, C., Ben‐Neriah, Y., & Levitzki, A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42864-5 · Cited by 93
Chromosome changes in malignant mesothelioma
Gibas, Z., Li, F. P., Antman, K. H., Bernal, S. D., Stahel, R. A., & Sandberg, A. A. (1986) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(86)90074-9 · Cited by 93
McKay, P. F. (2000) · Methods in molecular medicine · doi:10.1385/1-59259-076-4:407 · Cited by 92
Historical and Clinical Perspectives on Chromosomal Translocations
Wilch, E., & Morton, C. C. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-0593-1_1 · Cited by 108
Honda, H., Ushijima, T., Wakazono, K., Oda, H., Tanaka, Y., Aizawa, S., Ishikawa, T., Yazaki, Y., & Hirai, H. (2000) · Blood · doi:10.1182/blood.v95.4.1144.004k04_1144_1150 · Cited by 101
Zhou, H., Mak, P. Y., Mu, H., Mak, D. H., Zeng, Z., Cortes, J., Liu, Q., Andreeff, M., & Carter, B. Z. (2017) · Leukemia · doi:10.1038/leu.2017.87 · Cited by 91
Aichberger, K. J., Mayerhofer, M., Krauth, M.-T., Vales, A., Kondo, R., Derdak, S., Pickl, W. F., Selzer, E., Deininger, M., Druker, B. J., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0972 · Cited by 91
Kurzrock, R., Kantarjian, H., Shtalrid, M., Gutterman, J., & Talpaz, M. (1990) · Blood · doi:10.1182/blood.v75.2.445.445 · Cited by 91
Chromosomal localization of the human c-fmsoncogene
Groffen, J., Heisterkamp, N., Spurr, N. K., Dana, S. L., Wasmuth, J. J., & Stephenson, J. R. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.18.6331 · Cited by 90
Self-citationAmplified C lambda and c-abl genes are on the same marker chromosome in K562 leukemia cells.
Selden, J. R., Emanuel, B. S., Wang, E., Cannizzaro, L. A., Palumbo, A. P., Erikson, J., Nowell̀, P. C., Rovera, G., & Croce, C. M. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.23.7289 · Cited by 88
Expression of c-abl in Philadelphia-positive acute myelogenous leukemia
Kurzrock, R., Shtalrid, M., Talpaz, M., Kloetzer, W. S., & Gutterman, J. U. (1987) · Blood · doi:10.1182/blood.v70.5.1584.1584 · Cited by 87
Gundry, M. C., & Vijg, J. (2011) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2011.10.001 · Cited by 95
Kelliher, M. A., Knott, A., McLaughlin, J., Witte, O. N., & Rosenberg, N. E. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.9.4710 · Cited by 86
Implicating the bcr/abl Gene in the Pathogenesis of Philadelphia Chromosome-Positive Human Leukemia
Daley, G. Q., & Ben‐Neriah, Y. (1991) · Advances in cancer research · doi:10.1016/s0065-230x(08)60998-7 · Cited by 86
Reanalysis of RNA-Sequencing Data Reveals Several Additional Fusion Genes with Multiple Isoforms
Kangaspeska, S., Hultsch, S., Edgren, H., Nicorici, D., Murumägi, A., & Kallioniemi, O. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048745 · Cited by 98
Oncogene expression in human leukemia
Blick, M. B., Westin, E., Gutterman, J., Wong-Staal, F., Gallo, R. C., McCredie, K., Keating, M. J., & Murphy, E. (1984) · Blood · doi:10.1182/blood.v64.6.1234.1234 · Cited by 89
Oncogenes in Retroviruses and Cells: Biochemistry and Molecular Genetics
Bister, K., & Jansen, H. W. (1986) · Advances in cancer research · doi:10.1016/s0065-230x(08)60199-2 · Cited by 95
STI571: A Paradigm of New Agents for Cancer Therapeutics
Mauro, M. J., O'Dwyer, M. E., Heinrich, M. C., & Druker, B. J. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.1.325 · Cited by 127
Blastic transformation of p53-deficient bone marrow cells by p210 bcr/abl tyrosine kinase
Skórski, T., Nieborowska-Skorska, M., Wlodarski, P. K., Perrotti, D., Martinez, R., Wasik, M. A., & Calabretta, B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.13137 · Cited by 90
Ramaraj, P., Singh, H., Niu, N., Chu, S., Holtz, M., Yee, J. K., & Bhatia, R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3656 · Cited by 68
Fuchs, U., Rehkamp, G., Haas, O. A., Slany, R., König, M., Bojesen, S., Bohle, R. M., Damm-Welk, C., Ludwig, W.-D., Harbott, J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121433898 · Cited by 83
Evidence that the phl Gene Encodes a 160,000-Dalton Phosphoprotein with Associated Kinase Activity
Stam, K., Heisterkamp, N., Reynolds, F. H., & Groffen, J. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.5.1955 · Cited by 83
“We have previously localized the human c-abl oncogene to chromosome 9 (10) and shown that the tip of the long arm of chromosome 9, including c-abl, is consistently translocated to the breakpoint cluster region (bcr) within the phl gene on chromosome 22 (6, 8).”
BackgroundSelf-citationA Novel Human Gene Closely Related to the abl Proto-Oncogene
Kruh, G. D., King, C. R., Kraus, M. H., Popescu, N. C., Amsbaugh, S. C., McBride, W. O., & Aaronson, S. A. (1986) · Science · doi:10.1126/science.3787260 · Cited by 92
Marmont, A. M., Frassoni, F., Bacigalupo, A. P., Podestà, M., Piaggio, G., Lint, M. T. V., Caimo, A., & De Filippi, S. (1984) · New England Journal of Medicine · doi:10.1056/nejm198404053101408 · Cited by 83
Targeting chromatin complexes in fusion protein-driven malignancies
Brien, G. L., Stegmaier, K., & Armstrong, S. A. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0132-x · Cited by 86
Cornejo, M. G., Kharas, M. G., Werneck, M. B., Bras, S. L., Moore, S. A., Ball, B., Beylot-Barry, M., Rodig, S. J., Aster, J. C., Lee, B. H., et al. (2009) · Blood · doi:10.1182/blood-2008-06-164368 · Cited by 81
Holtz, M., Forman, S. J., & Bhatia, R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2014 · Cited by 82
“Chronic myelogenous leukemia (CML) is a hematopoietic stem cell malignancy characterized by the t(9;22) chromosomal translocation that generates the BCR/ABL oncogene (1, 2).”
BackgroundHigh frequency of N-ras activation in acute myelogenous leukemia
Sw, N., Mh, K., Srivastava, S., Levine, P., & Aaronson, S. A. (1986) · Blood · doi:10.1182/blood.v67.3.753.753 · Cited by 82
Homology between phosphotyrosine acceptor site of human c-abl and viral oncogene products
Groffen, J., Heisterkamp, N., Reynolds, F. H., & Stephenson, J. R. (1983) · Nature · doi:10.1038/304167a0 · Cited by 82
Self-citationApproved and Experimental Small‐Molecule Oncology Kinase Inhibitor Drugs: A Mid‐2016 Overview
Fischer, P. M. (2017) · Medicinal Research Reviews · doi:10.1002/med.21409 · Cited by 82
Renshaw, M. W., McWhirter, J. R., & Wang, J. Y. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.3.1286 · Cited by 81
“Human chronic myelogenous leukemia (CML) and a subset of acute lymphocytic leukemia (ALL) are characterized by the Philadelphia chromosome (Ph1), a translocation in which the breakpoint cluster region (bcr) gene on chromosome 22 becomes fused to the c-abl proto-oncogene on chromosome 9 (6, 12, 30).”
BackgroundYoffe, G., Blick, M. B., Kantarjian, H. M., Spitzer, G., Gutterman, J. U., & Talpaz, M. (1987) · Blood · doi:10.1182/blood.v69.3.961.961 · Cited by 81
Expression of Cellular Oncogenes
Müller, R., & Verma, I. M. (1984) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-69677-0_4 · Cited by 86
Translocation of c-abl to “Masked” Ph in chronic myeloid leukemia
Hagemeijer, A., de Klein, A., Gödde-Salz, E., Turc‐Carel, C., Smit, E., van Agthoven, A. J., & Grosveld, G. C. (1985) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(85)90059-7 · Cited by 80
Self-citationDobrovic, A., Trainor, K., & Morley, A. (1988) · Blood · doi:10.1182/blood.v72.6.2063.2063 · Cited by 80
Molecular Genetic Analysis of Human Lymphoid Neoplasms
Waldmann, T. A., Korsmeyer, S. J., BAKHSHI, A., ARNOLD, A., & KIRSCH, I. R. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-102-4-497 · Cited by 79
The role of interferon-alpha in the treatment of chronic myeloid leukemia
Kujawski, L. A., & Talpaz, M. (2007) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2007.06.015 · Cited by 86
“In the 1980s as interferon-alpha research was ongoing, advances in the mapping of oncogenes revealed that the c-ABL tyrosine kinase typically found on chromosome 9 was now moved to chromosome 22 in patients with CML [40].”
BackgroundDudley, J. P., & Risser, R. (1984) · Journal of Virology · doi:10.1128/jvi.49.1.92-101.1984 · Cited by 78
“Molecular changes identified include the chromosomal translocations involving the c-myc oncogene and the immunoglobulin a heavy-chain locus (9, 30, 46), amplification of c-myc in a human myeloid leukemia (7, 11), translocation of c-abl in the Philadelphia chromosome of chronic myelocytic leukemia (12), and rearrangeme…”
BackgroundMultiple endocrine neoplasia type 1 (MEN1)
Pang, J. T., & Thakker, R. V. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)00387-k · Cited by 79
Karyotypic and clinical findings in a consecutive series of children with acute lymphocytic leukemia
Heerema, N. A., Palmer, C. G., & Baehner, R. L. (1985) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(85)90027-5 · Cited by 77
Bone Marrow Transplantation for Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Stockshläder, M., Hegewisch-Becker, S., Krüger, W., Dieck, A. T., Hoffknecht, M., Berger, C., Kohlschütter, B., Martin, H., Peters, S., Kabisch, H., et al. (1997) · Hämatologie und Bluttransfusion · doi:10.1007/978-3-642-60377-8_107 · Cited by 77
O'Dwyer, M. E., & Druker, B. J. (2000) · The Lancet Oncology · doi:10.1016/s1470-2045(00)00149-2 · Cited by 75
Vaerman, J. L., Moureau, P., Deldime, F., Lewalle, P., Lammineur, C., Morschhauser, F., & Martiat, P. (1997) · Blood · doi:10.1182/blood.v90.1.331 · Cited by 75
Lundell, B., McCarthy, J. B., Kovach, N. L., & Verfaillie, C. M. (1996) · Blood · doi:10.1182/blood.v87.6.2450.bloodjournal8762450 · Cited by 76
Loss-of-function genetic screens as a tool to improve the diagnosis and treatment of cancer
Mullenders, J., & Bernards, R. (2009) · Oncogene · doi:10.1038/onc.2009.295 · Cited by 81
Wang, X., Charng, W., Chen, C., Rosenfeld, J. A., Shamsi, A. A., Al‐Gazali, L., McGuire, M., Mew, N. A., Arnold, G. L., Qu, C., et al. (2017) · Nature Genetics · doi:10.1038/ng.3815 · Cited by 75
“Anomalies of the 12 fetuses included scoliosis/vertebral defects (3), CHD (2), hypospadias (2), and pyloric stenosis (1)2,3.”
BackgroundDrug resistance: genotype versus phenotype--thirty-second G. H. A. Clowes Memorial Award Lecture.
Biedler, J. L. (1994) · PubMed · Cited by 74
Molecular analysis of both translocation products of a Philadelphia-positive CML patient
de Klein, A., van Agthoven, T., Groffen, C., Heisterkamp, N., Groffen, J., & Grosveld, G. C. (1986) · Nucleic Acids Research · doi:10.1093/nar/14.17.7071 · Cited by 74
Self-citationCommonality but Diversity in Cancer Gene Fusions
Rabbitts, T. H. (2009) · Cell · doi:10.1016/j.cell.2009.04.034 · Cited by 73
“In the 1980s, the breakpoint of the Philadelphia chromosome was cloned to reveal the fusion of the BCR and ABL genes (Figure 1A), and the resulting fusion protein was shown to be oncogenic (Bartram et al., 1983; de Klein et al., 1982).”
BackgroundInsulin-like growth factor II and PAX3-FKHR cooperate in the oncogenesis of rhabdomyosarcoma.
Wang, W., Kumar, P., Wang, W., Epstein, J. A., Helman, L. J., Moore, J., & Kumar, S. (1998) · PubMed · Cited by 72
Flow cytometric immunobead assay for the detection of BCR–ABL fusion proteins in leukemia patients
Weerkamp, F., Spaeny-Dekking, E. H. A., Ng, Y. Y., van der Velden, V. H. J., Wai, H., Böttcher, S., Brüggemann, M., van der Sluijs, A. J., Koning, A. J., Boeckx, N., et al. (2009) · Leukemia · doi:10.1038/leu.2009.93 · Cited by 74
“showed in 1982 that t(9;22)(q34;q11) fuses the upstream part of the BCR gene to the downstream part of the ABL gene”
BackgroundThe Discovery of Reverse Transcriptase
Coffin, J. M., & Fan, H. (2016) · Annual Review of Virology · doi:10.1146/annurev-virology-110615-035556 · Cited by 71
Cancer: We Should Not Forget The Past
Lonardo, A. D., Nasi, S., & Pulciani, S. (2014) · Journal of Cancer · doi:10.7150/jca.10336 · Cited by 93
The human c-ros gene (ROS) is located at chromosome region 6q16----6q22.
Nagarajan, L., Louie, E., Tsujimoto, Y., Balduzzi, P. C., Huebner, K., & Croce, C. M. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.17.6568 · Cited by 71
Lewis, I. D., McDiarmid, L. A., Samels, L. M., To, L. B., & Hughes, T. P. (1998) · Blood · doi:10.1182/blood.v91.2.630 · Cited by 70
Expression of bcr And bcr-abl Fusion Transcripts in Normal and Leukemic Cells
Collins, S., Coleman, H., & Groudine, M. T. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.8.2870 · Cited by 70
Heim, S., & Mitelman, F. (1987) · Human Genetics · doi:10.1007/bf00273843 · Cited by 70
Development of a panel of monochromosomal somatic cell hybrids for rapid gene mapping
Kelsell, D. P., Rooke, L. J., Warne, D., Bouzyk, M., CULLIN, L., Cox, S., West, L. F., Povey, S., & Spurr, N. K. (1995) · Annals of Human Genetics · doi:10.1111/j.1469-1809.1995.tb00743.x · Cited by 70
Self-citationA molecular genetic linkage map of mouse chromosome 2
Siracusa, L. D., Silan, C. M., Justice, M. J., Mercer, J. A., Bauskin, A. R., Ben‐Neriah, Y., Duboule, D., Hastie, N. D., Copeland, N. G., & Jenkins, N. A. (1990) · Genomics · doi:10.1016/0888-7543(90)90479-e · Cited by 73
White, D. L., Saunders, V. A., Grigg, A., Arthur, C., Filshie, R., Leahy, M. F., Lynch, K., To, L. B., & Hughes, T. P. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.9499 · Cited by 74
Sillaber, C., Mayerhofer, M., Böhm, A., Vales, A., Gruze, A., Aichberger, K. J., Esterbauer, H., Pfeilstöcker, M., Sperr, W. R., Pickl, W. F., et al. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01892.x · Cited by 75
Huret, J. L. (1990) · Human Genetics · doi:10.1007/bf00193575 · Cited by 68
Molecular Cloning of A Novel Human Leukemia-Associated Gene
Zhu, X., Kozarsky, K., Strahler, J. R., Eckerskorn, C., Lottspeich, F., Melhem, R., Lowe, J. B., Fox, D. A., Hanash, S., & Atweh, G. F. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)71714-6 · Cited by 69
Metadata
- Authors
- Klein, A. D., Kessel, A. G. V., Grosveld, G., Bartram, C. R., Hagemeijer, A., Bootsma, D., Spurr, N. K., Heisterkamp, N., Groffen, J., & Stephenson, J. R.
- Affiliations
- Erasmus University Rotterdam (NL)
- National Cancer Institute (US)
- Venue
- Nature
- Published
- 1982-12
- Volume
- 300
- Issue
- 5894
- Pages
- 765-767
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2060833726
- Cited by
- 1,378
- References
- 27
- Citations by year
- 2026: 8 · 2025: 6 · 2024: 17 · 2023: 12 · 2022: 25 · 2021: 17 · 2020: 18 · 2019: 15 · 2018: 23 · 2017: 28 · 2016: 24 · 2015: 33 · 2014: 16 · 2013: 26 · 2012: 33
- FWCI
- 50.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Chronic Myeloid Leukemia Treatments
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Keywords
- Philadelphia chromosome, chromosome 9, chromosome 22, reciprocal translocation, cellular oncogenes, somatic cell hybrids
- MeSH terms
- Chromosomes, Human, 21-22 and Y, Chromosomes, Human, 6-12 and X, DNA, Neoplasm, Gene Expression Regulation, Humans, Leukemia, Myeloid, Oncogenes, Translocation, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.